Literature DB >> 27363760

Overview of Botulinum Toxins for Aesthetic Uses.

Michael S Gart1, Karol A Gutowski2.   

Abstract

Botulinum toxin type A (BTA) can be used for facial aesthetics. The 3 currently available BTA types include onabotulinumtoxinA (Botox; Botox Cosmetic, Allergan, Irvine, CA), abobotulinumtoxinA (Dysport; Ipsen, Ltd, Berkshire, UK), and incobotulinumtoxinA (Xeomin; Merz Pharmaceuticals, Frankfurt, Germany). The mechanism of action and clinical uses for treatment of dynamic lines of the forehead, brow, glabella, lateral orbit, nose, and lips are presented, as well as treatment of masseter hypertrophy, platysmal bands, and improvements of the perioral region. Specific BTA injection sites and suggested doses are presented.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Botox; Botulinum toxin; Dysport; Myobloc; Neuromodulators; Neurotoxins; Xeomin

Mesh:

Substances:

Year:  2016        PMID: 27363760     DOI: 10.1016/j.cps.2016.03.003

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  12 in total

Review 1.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  COMMENTARY ON BOTULINUM TOXIN INJECTIONS: A CALL FOR IMPROVED ACCURACY.

Authors:  Steven G Yoelin; Marilyn S Kwolek; Jon E Block
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

3.  Botulinum Neurotoxins: Mechanism of Action.

Authors:  O Rossetto; M Pirazzini; F Fabris; C Montecucco
Journal:  Handb Exp Pharmacol       Date:  2021

4.  EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial.

Authors:  Eduardo Guimarães Hourneaux de Moura; Igor Braga Ribeiro; Mariana Souza Varela Frazão; Luiz Henrique Mazzonetto Mestieri; Diogo Turiani Hourneaux de Moura; Creusa Maria Roveri Dal Bó; Vitor Ottoboni Brunaldi; Eduardo Turiani Hourneaux de Moura; Gabriel Cairo Nunes; Fábio Alberto Castillo Bustamante; Manoel Dos Passos Galvão Neto; Sergio Eiji Matuguma; Wanderley Marques Bernardo; Marco Aurélio Santo
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

5.  Botulinum toxin A-induced muscle paralysis stimulates Hdac4 and differential miRNA expression.

Authors:  Leah E Worton; Edith M Gardiner; Ronald Y Kwon; Leah M Downey; Brandon J Ausk; Steven D Bain; Ted S Gross
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

6.  Anatomical Study and Comprehensive Review of the Incisivus Labii Superioris Muscle: Application to Lip and Cosmetic Surgery.

Authors:  Joe Iwanaga; Koichi Watanabe; Cameron K Schmidt; Vlad Voin; Fernando Alonso; Rod J Oskouian; R Shane Tubbs
Journal:  Cureus       Date:  2017-09-15

7.  OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays.

Authors:  David Rupp; Greg Nicholson; David Canty; Joanne Wang; Catherine Rhéaume; Linh Le; Lance E Steward; Mark Washburn; Birgitte P Jacky; Ron S Broide; Wolfgang G Philipp-Dormston; Mitchell F Brin; Amy Brideau-Andersen
Journal:  Toxins (Basel)       Date:  2020-06-13       Impact factor: 4.546

Review 8.  Botulinum Toxin Application in Facial Esthetics and Recent Treatment Indications (2013-2018).

Authors:  Vivekanand Kattimani; Rahul Vinay Chandra Tiwari; Khalid Gufran; Bharti Wasan; P H Shilpa; Anas Abdul Khader
Journal:  J Int Soc Prev Community Dent       Date:  2019-04-12

9.  Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors:  Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-24

10.  Hyaluronic Acid Fillers Enriched with Glycine and Proline in Eyebrow Augmentation Procedure.

Authors:  Antonio Scarano; Biagio Rapone; Domenico Amuso; Francesco Inchingolo; Felice Lorusso
Journal:  Aesthetic Plast Surg       Date:  2021-07-06       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.